On Saturday, Union Finance Minister Nirmala Sitharaman announced exemption of custom duty on 36 life saving drugs. This move will be a great relief to those dealing with cancer and rare diseases. Additionally, 37 more medicines and 13 new patient assistance programs have also been exempted from the basic customs duty.
The government had earlier cut customs duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to nil.
